What is well-established: Kisspeptin is essential for normal reproductive hormone signaling Kisspeptin-10 and kisspeptin-54 can trigger LH release in clinical settings Kisspeptin-based ovulation triggering in IVF shows genuine clinical promise Kisspeptin dysregulation is measurably involved in PMOS and FHA pathophysiology What is still under investigation: Optimal dosing, timing, and delivery protocols outside IVF contexts Long-term safety data for ongoing or cyclical therapeutic use Clinical protocols for kisspeptin in anovulation management outside of assisted reproduction Whether exogenous kisspeptin-10 (the shorter fragment) produces equivalent clinical effects to kisspeptin-54 in fertility contexts As with many emerging peptide therapies, kisspeptin should be approached with informed expectations
Prevention hinges on tight glycemic control, healthy lifestyle (diet, exercise, smoking cessation), and patient education on foot hygiene and self-examination [121]
To do so, stable isotope labeling and mass spectrometry imaging are leveraged via infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI)
Novo Nordisk says fulfilling the demand could take years
When administered by trained professionals using authentic products, it is generally considered safe